Menu

Blog

Archive for the ‘biotech/medical’ category: Page 749

Jan 8, 2023

Stability AI’s Emad Mostaque, The Future of Generative AI, Real-Time Movies, Societal Impact

Posted by in categories: biotech/medical, business, education, robotics/AI

In the 46th episode, Stability AI CEO Emad Mostaque discusses the future of AI. From being only years out from generating entire movies in real-time to how it’s revolutionizing the healthcare industry and could help identify cancer. Plus its benefits in education, charities, the potential regulations, and societal impact, and Stable Diffusion becoming the most popular open-source software in the world.

(0:00) Intro.
(1:03) Introducing Emad Mostaque.
(1:27) Generative AI
(9:52) Computing power and AI
(12:23) How Emad got into AI
(14:49) Open-source AI
(20:19) Growth of Stable Diffusion.
(21:57) Lensa.
(25:39) Power of Creativity.
(30:00) Ramifications of AI
(34:09) State of the industry.
(37:32) Business model for AI
(43:28) AI use cases.
(48:11) Societal impact.
(51:39) Becoming a public figure.
(55:41) Outro.

Continue reading “Stability AI’s Emad Mostaque, The Future of Generative AI, Real-Time Movies, Societal Impact” »

Jan 8, 2023

How to Turn Air Pollution into Gleaming Diamonds

Posted by in categories: biotech/medical, finance

Year 2021 This also another use for air pollution into diamonds.


Mining diamonds is a notoriously destructive and exploitative process, both socially and environmentally. On a mission to produce diamonds sustainably and ethically, one company discovered a way to—quite literally—pull diamonds out of thin air.

According to the International Gem Society, 250 tons of soil are moved for each carat of mined diamond, wreaking havoc on ecosystems, wildlife, and the water table. Nearly 20 years have passed since the United Nations established the Kimberley Process, a certification to address human rights abuses in the mining industry and eradicate conflict diamonds from the global market. Also known as “blood diamonds,” conflict diamonds are mined in rebel-controlled areas and sold to help finance armed conflicts. The Human Rights Watch says that rebel rule, forced labor, and violence are still rampant in the industry.

Continue reading “How to Turn Air Pollution into Gleaming Diamonds” »

Jan 8, 2023

A New Weapon Against Antibiotic-Resistant Bacteria

Posted by in categories: biotech/medical, health

UNIGE researchers have discovered that a medication commonly used to treat herpes can combat an antibiotic-resistant bacterium by disrupting its defense mechanisms.

Antibiotic resistance, or the ability of bacteria to develop resistance to treatment with antibiotics, has become a major concern for global health. The World Health Organization (WHO) considers it one of the greatest threats to health. The overuse of antibiotics has contributed to the emergence of antibiotic-resistant bacteria, which can cause serious illness and death. One example of an antibiotic-resistant pathogen is Klebsiella pneumoniae, a bacterium commonly found in hospitals and known for its virulence. Without effective treatment options, we could see a resurgence of diseases such as pneumonia and salmonella, which were once easily treated with antibiotics.

Researchers at the University of Geneva (UNIGE) have found that edoxudine, an anti-herpes molecule developed in the 1960s, can disrupt the protective surface of Klebsiella bacteria and make them more vulnerable to being eliminated by immune cells. The researchers’ findings were recently published in the journal PLOS ONE.

Jan 8, 2023

Ep. 102: Genetic engineering and the biological basis of intelligence. | Steven Hsu

Posted by in categories: bioengineering, biotech/medical, computing, genetics, mathematics

Since the discovery of genetics, people have dreamed of being able to correct diseases, select traits in children before birth, and build better human beings. Naturally, many serious technical and ethical questions surround this endeavor. Luckily, tonights’ guest is as good a guide as we could hope to have.

Dr. Steve Hsu is Professor of Theoretical Physics and of Computational Mathematics, Science, and Engineering at Michigan State University. He has done extensive research in the field of computational genomics, and is the founder of several startups.

#geneticengineering #intelligence

Jan 8, 2023

AI is helping doctors spot and treat strokes much faster

Posted by in categories: biotech/medical, robotics/AI

“Brainomix specialise in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions in stroke imaging”

https://www.openaccessgovernment.org/brainomix-stroke-imaging-solutions/122141/


The use of artificial intelligence (AI) technology has helped to triple the number of patients who recover from a stroke in England.

Continue reading “AI is helping doctors spot and treat strokes much faster” »

Jan 8, 2023

How these factors could lead to better nanomedicine treatments

Posted by in categories: biological, biotech/medical, particle physics

Better treatments are definitely on the way.

Nanomedicines took the spotlight during the COVID-19 pandemic. Researchers are using these very small and intricate materials to develop diagnostic tests and treatments. Nanomedicine is already used for various diseases, such as the COVID-19 vaccines and therapies for cardiovascular disease. The “nano” refers to the use of particles that are only a few hundred nanometers in size, which is significantly smaller than the width of a human hair.


NIH Image Gallery/Flickr.

Continue reading “How these factors could lead to better nanomedicine treatments” »

Jan 8, 2023

AI Enters The Mainstream With ChatGPT

Posted by in categories: biotech/medical, robotics/AI

Let me pick up where I left off ahead of Christmas by reiterating the fives themes for 2023 (‘War by Other Means’) that I had put together with David Skilling. The note details the trends we expect to materialise through the year as intense strategic competition between regions takes hold.


ChatGPT brings AI into our everyday lives, highlighting also its use in many other domains such as medicine and justice.

Jan 8, 2023

Mojo Vision puts contact lens production ‘on hold’ as it lays off 75% of staff

Posted by in categories: augmented reality, biotech/medical, computing, economics

We’ve met with Mojo Vision for several CESes, watching the startup’s AR contact lenses develop, year by year. These sorts of things take a lot of time and money, of course — and these days it seems increasingly difficult to find either. Today, the California-based firm announced that it is “decelerating” work on the Mojo Lens, citing, “significant challenges in raising capital.”

In an announcement posted to it site, CEO Drew Perkins blames insurmountable headwinds, including the bad economy and the “yet-to-be proven market potential for advanced AR products” in its ability to raise the necessary funding required to keep the project afloat.

“Although we haven’t had the chance yet to see it ship and to reach its full potential in the marketplace, we have proven that what was once considered science fiction can be developed into a technical reality,” Perkins writes. “Even though the pursuit of our vision for Invisible Computing is on hold for now, we strongly believe that there will be a future market for Mojo Lens and expect to accelerate it when the time is right.”

Jan 8, 2023

Controlled, localized delivery of blood thinner may improve blood clot treatment

Posted by in categories: biotech/medical, engineering

Heparin has long been used as a blood thinner, or anticoagulant, for patients with blood clotting disorders or after surgery to prevent complications. But the medication remains difficult to dose correctly, potentially leading to overdosing or underdosing.

A team of Penn State researchers combined with a , peptide, to slow down the release of the drug and convey the directly to the site of a clot. They published their findings in the journal Small.

“We wanted to develop a material that can gradually deliver heparin over time rather than the current iteration that gets cleared from the body in a couple of hours,” said corresponding author Scott Medina, Penn State associate professor of biomedical engineering. “We also wanted to deliver the drug through the skin instead of through an IV.”

Jan 8, 2023

COVID-19 Defence May Soon Have a New Weapon In Our Collective Arsenal

Posted by in categories: biotech/medical, futurism

A new drug that contains an ACE2 decoy molecule may be the way we stop COVID-19 permanently.


What’s Needed is a New Approach

A recent paper appearing in Science Advances published on December 7, 2022, describes a new approach to tackling COVID-19. A new drug in animal trials has shown effectiveness in stopping the spread of coronaviruses and all variants. It is the way this drug works that gives it a unique advantage not just to stop present Omicron and other COVID-19 versions but all future evolutions of the virus and other coronaviruses.

Continue reading “COVID-19 Defence May Soon Have a New Weapon In Our Collective Arsenal” »

Page 749 of 2,723First746747748749750751752753Last